| Financial Year |
March 31 2023 |
| Monetary Funds |
298,279,020.80 |
| Held-for-trading Financial Assets |
2,000.00 |
| Notes Receivable |
15,944,243.86 |
| Accounts Receivable |
473,023,865.46 |
| Advances to Suppliers |
151,148,682.92 |
| Other Receivables |
57,401,707.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
218,550,579.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,011.69 |
| Other Current Assets |
15,883,633.76 |
| Total Current Assets |
1,258,119,244.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,427,194.45 |
| Investment Properties |
-- |
| Fixed Assetes |
430,888,404.20 |
| Under-construction Projects |
1,982,182.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
412,859,703.34 |
| R&D expenses |
-- |
| Goodwill |
268,260,389.86 |
| Long-Term Deferred and Prepaid Expenses |
27,714,453.48 |
| Deferred Income Tax Assets |
159,583,348.01 |
| Other Non-Current Assets |
38,757,632.21 |
| Sub-Total of Non-Current Assets |
1,520,032,209.67 |
| Total Assets |
2,778,151,454.16 |
| Short-Term Loans |
520,314,108.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
92,496,628.00 |
| Accounts Payable |
356,424,240.12 |
| Accounts Received In Advance |
76,000.00 |
| Employee Compensation Payable |
22,349,199.78 |
| Taxes Payable |
15,696,788.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
48,703,768.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
158,027,103.78 |
| Other Current Liabilities |
7,707,640.08 |
| Sub-Total of Current Liabilities |
1,281,050,128.29 |
| Long-term Loans |
284,438,333.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
93,497,610.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
893,332.51 |
| Deferred Income Tax Liabilities |
61,958,073.41 |
| Other Non-Current Liabilities |
10,450,000.00 |
| Sub-Total of Non-Current Liabilities |
490,658,555.39 |
| Total Liabilities |
1,771,708,683.68 |
| Paid-In Capital(Or Share Stock) |
1,094,115,412.00 |
| Capital Surplus |
448,539,692.27 |
| Surplus Reserve |
65,759,466.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-886,439,449.72 |
| Minority Stockholder's Interest |
402,056,622.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
604,386,148.22 |
| Owner's Equity（Stockholder's Equity） |
1,006,442,770.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,778,151,454.16 |
